About armata pharmaceuticals - ARMP
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded in 1989 and is headquartered in Los Angeles, CA.
ARMP At a Glance
Armata Pharmaceuticals, Inc.
5005 McConnell Avenue
Los Angeles, California 90066
| Phone | 1-310-655-2928 | Revenue | 5.17M | |
| Industry | Biotechnology | Net Income | -18,916,000.00 | |
| Sector | Health Technology | 2024 Sales Growth | 14.242% | |
| Fiscal Year-end | 12 / 2025 | Employees | 60 | |
| View SEC Filings |
ARMP Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 12.93 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -4.479 |
| Enterprise Value to Sales | 35.586 |
| Total Debt to Enterprise Value | 0.687 |
ARMP Efficiency
| Revenue/Employee | 86,233.333 |
| Income Per Employee | -315,266.667 |
| Receivables Turnover | 6.954 |
| Total Asset Turnover | 0.049 |
ARMP Liquidity
| Current Ratio | 0.234 |
| Quick Ratio | 0.234 |
| Cash Ratio | 0.193 |
ARMP Profitability
| Gross Margin | 74.391 |
| Operating Margin | -820.178 |
| Pretax Margin | -365.597 |
| Net Margin | -365.597 |
| Return on Assets | -18.076 |
| Return on Equity | N/A |
| Return on Total Capital | -24.098 |
| Return on Invested Capital | -33.205 |
ARMP Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | 161.174 |
| Total Debt to Total Assets | 127.366 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | 105.903 |